---
schema_version: "secwatch.filing_event.v1"
accession: "0001829126-24-002584"
form_type: "8-K"
ticker: "CFOR"
cik: "0001293818"
company_name: "CapForce Inc."
filed_at: "2024-04-17T23:59:59+00:00"
generated_at: "2026-06-03T21:33:43.501261+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# OpGen appoints David Lazar as CEO with deferred salary and concurrent CEO roles

## Summary
- David Lazar, age 33, appointed CEO effective April 1, 2024; also serves as Chairman of the Board.
- Base salary $406,000 per annum, fully deferred until Compensation Committee determines sufficient liquidity.
- Three-year term; Lazar concurrently serves as CEO of Titan Pharmaceuticals (TTNP) and Minim, Inc. (MINM).
- Annual bonus at 100% base salary; special bonus: 3% of change-in-control valuation increase, $203k per $1M+ capital raise.
- Severance includes salary continuation for 12 months or remaining term, medical reimbursement, prorated bonus, accelerated vesting.

## SEC filing metadata
- accession: 0001829126-24-002584
- form_type: 8-K
- ticker: CFOR
- cik: 0001293818
- company_name: CapForce Inc.
- filed_at: 2024-04-17T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1293818/000182912624002584/0001829126-24-002584-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1293818/000182912624002584/opgen_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001829126-24-002584
- JSON: https://secwatch.observer/filing/0001829126-24-002584.json
- Plain text: https://secwatch.observer/filing/0001829126-24-002584.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.